You have access
Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer
HIROMICHI KAWAIDA, HIROSHI KONO, HIDETAKE AMEMIYA, RYOU SAITOU, ATSUSHI YAMAMOTO, NAOHIRO HOSOMURA, MITSUAKI WATANABE, AYAKO KIMURA, SHINJI FURUYA, HIROKI SHIMIZU, HIDENORI AKAIKE, YOSHIHIKO KAWAGUCHI, MAKOTO SUDO, JUN ITAKURA, HIROSHI HAYAKAWA, HIROKO SHINDO, EI TAKAHASHI, SHINICHI TAKANO, MITSUHARU FUKASAWA, SHINTARO ICHIKAWA, HIDEKI FUJII and DAISUKE ICHIKAWA
Anticancer Research November 2018, 38 (11) 6537-6542; DOI: https://doi.org/10.21873/anticanres.13019